Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04274179 · ClinicalTrials.gov registry record · Phase 3
Ketogenic Diet for New-Onset Absence Epilepsy
A Phase 3 study of Ketogenic Dieting and Epilepsy, Absence, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04274179 is a Phase 3 study of Ketogenic Dieting and Epilepsy, Absence that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 40 participants, roughly in line with the 39-participant average among 5 other Ketogenic Dieting trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT04274179, a Phase 3 study of Ketogenic Dieting and Epilepsy, Absence, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The ketogenic diet is a medical therapy for epilepsy that is used nearly predominantly for refractory epilepsy (after 2-3 drugs have been tried and failed). However, there is both published evidence for first-line use (infantile spasms, Glut1 deficiency syndrome) and also anecdotal experience (families choosing to change the child's (or the family' own) diet rather than use anticonvulsant medications). Childhood absence epilepsy (refractory) has been published as being responsive to ketogenic diet therapy by the investigators' group previously. This is a small, prospective, 3 month trial to assess if using a modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy. The investigators will compare to a group of children in which the parents have declined and chose to start anticonvulsant medications.
Conditions Studied
Interventions
- OTHER Modified Atkins Diet
- DRUG Absence epilepsy medications
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-08-10 |
| Est. Completion | 2026-05-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04274179
The ClinicalTrials.gov registry entry for NCT04274179 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 39-participant average among 5 other Ketogenic Dieting trials with a reported enrollment target. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Ketogenic Dieting appearing as the primary indexed condition, and to 2 interventions - of which Modified Atkins Diet is the first listed.
NCT04274179 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04274179 about?
NCT04274179 is a clinical study titled "Ketogenic Diet for New-Onset Absence Epilepsy". The ketogenic diet is a medical therapy for epilepsy that is used nearly predominantly for refractory epilepsy (after 2-3 drugs have been tried and failed). However, there is both published evidence for first-line use (infantile spasms, Glut1 deficiency syndrome) and also anecdotal experience (famil...
What is the current status of trial NCT04274179?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2020-08-10. Estimated completion is 2026-05-01.
What conditions does trial NCT04274179 study?
This clinical trial studies the following conditions: Ketogenic Dieting, Epilepsy, Absence, Absence Epilepsy.
What interventions are being tested in trial NCT04274179?
The interventions under investigation include: Modified Atkins Diet (OTHER), Absence epilepsy medications (DRUG).
Who is sponsoring clinical trial NCT04274179?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04274179 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ketogenic Dieting
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Nutritional Ketosis on Alcohol Metabolism
RECRUITING · Phase 2
-
Ketogenic Diet and Diabetes Demonstration Project
RECRUITING · NA
-
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
COMPLETED
-
Determining the Ergogenic Effects of Carb10™ Supplementation on Carbohydrate-Rich and Carbohydrate-Restricted Diets
COMPLETED · NA
-
Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.